Vaccines & Immune Biology

Shannon McMahon of the Heidelberg Institute of Global Health in Germany and Mark Donal Reñosa of the Research Institute for Tropical Medicine in the Philippines will create and test an intervention based on narrative and imagery to re-establish trust in vaccinations in Western Visayas, Philippines. Confidence in the safety of vaccines has recently dropped in the Philippines, exacerbated by controversy with a dengue vaccine in 2017. The country is now facing a measles outbreak, with a 3000% increase in cases in some areas.

Tapash Roy, Subhash Chandir and Toufiq Rahman of IRD Global in Singapore will improve child immunization coverage among the homeless, or floating, populations in urban slums in Bangladesh by offering vaccines during evening sessions at existing shelters. The mortality rate for children under five in Bangladesh is high, and many deaths would be preventable with better vaccination coverage.

Amos Kahwa of Damax Solutions Company Ltd. in Tanzania will use human-centered design principles to develop a community-supported, social marketing approach that breaks down misconceptions and psychosocial barriers to immunization in developing countries and thereby increases demand. Research has identified several causes of the current low demand for vaccinations including misconceptions about safety, inadequate knowledge of schedules, and negative experiences at clinics. Current approaches designed to increase demand such as better education and incentives have had a limited effect.

Anita Shet of Johns Hopkins School of Public Health in the U.S. will seek to increase childhood vaccination coverage in India and Nigeria by identifying opportunities for catch-up vaccinations when under-vaccinated children are hospitalized. Of the three million people who die each year from vaccine-preventable diseases, about half are children under the age of five, many of whom live in areas where vaccinations are available, but inequitably distributed.

Ernest Darhok of Broadreach in South Africa will use mobile technology to improve access to child immunization services for populations living on the Kenya-Uganda border and help ensure all children are fully vaccinated. Refugee populations living in cross-border settings and migrant communities are particularly difficult to cover because of limited access, poor coordination across borders, and lack of efficient tracking.

Caroline Aura from the University of Nairobi in Kenya will teach frontline health workers and caregivers new skills so they can apply simple techniques such as swaddling and rocking to lessen the pain and distress of infants during injections to improve vaccination rates. Vaccination rates are still too low in many low-resource settings, which may be due in part to the discomfort they cause infants. This in turn makes caregivers reluctant to obtain all the recommended vaccinations for their children.

Jessica Craig of the Center for Disease Dynamics, Economics and Policy in the U.S. will use existing food distribution networks in low-income countries to publicize the importance of vaccination and inform caregivers when, where, and how to access local vaccine services by printing them on food labels, food and water carrying tools, and receipts. They will test whether their approach can improve vaccination rates using one rural and one urban area each in Kenya and in the Central African Republic.

Feng Fu of Dartmouth College in the U.S. will use social networks to promote positive attitudes and overcome negative views of vaccinations and thereby increase demand. The success of vaccinations has led to steep declines in the incidence of many serious diseases. However, this has decreased the perception of disease risk and thereby lowered vaccination coverage as parents concerns switch to other factors, such as cost and the perceived risk of the vaccination itself, which are fueled via social media channels.

Martin Karplus of Harvard University in the U.S. will integrate informatics and artificial intelligence approaches to design stable, synthetic antigens based on the viral hemagglutinin (HA) protein to be used as a universal influenza vaccine. Seasonal influenza causes substantial morbidity worldwide, and the development of a universal vaccine is a global health priority. The current HA-based vaccines do not provide broad coverage against multiple strains, and must be administered annually because of the high mutability of the virus.

Patrick Wilson of the University of Chicago in the U.S. will generate a universal influenza vaccine based on multiple conserved and protective viral protein epitopes selected for their ability to produce a broad and lasting immune response. Influenza causes tens of thousands of deaths worldwide each year, and current vaccines designed around individual epitopes are only 20% to 60% effective.